# Solidarity/Tokomeza Ebola Trial

> **NCT05909358** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Makerere University** · enrollment: 2121 (estimated)

## Conditions studied

- Sudan Ebola Virus Vaccines

## Interventions

- **BIOLOGICAL:** CAd3
- **BIOLOGICAL:** ChAdox1
- **BIOLOGICAL:** rVSV-SUDV
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT05909358
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-07
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 2121 (ESTIMATED)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05909358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05909358, "Solidarity/Tokomeza Ebola Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05909358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*